887573-44-6Relevant articles and documents
SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES
-
, (2021/10/22)
Compounds having the structure of Formula (I) or pharmaceutically acceptable isomers, racemates, hydrates, solvates or salts thereof, where A, R1, R2a, R2b, R2c and R3 are as defined herein, are usefu
PESTICIDAL COMPOUNDS
-
, (2018/10/30)
The present invention relates to the compounds of formula (I), and the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof wherein the variables are defined according to the description, (I). The compounds of formula (I), as well as the N-oxides, stereoisomers, tautomers and agriculturally or veterinarily acceptable salts thereof, are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors
Fucini, Raymond V.,Hanan, Emily J.,Romanowski, Michael J.,Elling, Robert A.,Lew, Willard,Barr, Kenneth J.,Zhu, Jiang,Yoburn, Joshua C.,Liu, Yang,Fahr, Bruce T.,Fan, Junfa,Lu, Yafan,Pham, Phuongly,Choong, Ingrid C.,VanderPorten, Erica C.,Bui, Minna,Purkey, Hans E.,Evanchik, Marc J.,Yang, Wenjin
scheme or table, p. 5648 - 5652 (2009/06/30)
A series of 2-amino-pyrazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors based on a low micromolar hit. The SAR was developed to provide compounds exhibiting low nanomolar inhibitory activity of Plk1; the phenotype of treated cells is consistent with Plk1 inhibition. A co-crystal structure of one of these compounds with zPlk1 confirms an ATP-competitive binding mode.